STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET DENMARK TICKER: STENO
The Founders of STENOCARE have agreed to sell subscription rights, today, the last day of trading in subscription rights in the ongoing rights issue, in order to satisfy current demand at present market levels. The Company will confirm how many rights have been sold by the Founders following the close of trading today. The Founders are committed to re-invest all proceeds from such sales in the issue in order to maintain their position as “not-selling-shareholders” to the extent that the issue is not otherwise fully subscribed.
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by STENOCARE A/S for publication on June 9, 2020.